Efficacy and Safety of ReLEx Smile for Laser Correction of Myopia

NCT01481792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2016-05-12

No results posted yet for this study

Summary

Evaluation of the safety and efficacy of the Carl Zeiss Meditec VisuMax femtosecond laser for lamellar resection (ReLEx smile) in the reduction of myopia.

Conditions

  • Myopia

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2014-10-31
Completion
2015-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01481792 on ClinicalTrials.gov